Phase 2 N=22 Dose-finding Study of Moxidectin for Treatment of Scabies
Scabies
Primary: Mortality Rate for Adult Scabies Mites — 2; 6; 8; 14 Adult mites
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=254 Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies
Scabies
Primary: Number of Patients in Each Treatment Group With Therapeutic Cure (Parasitological Cure Plus Clinical Cure) of Scabies — 83; 86 Participants
Phase 4 N=104 Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon
Scabies · Households
Primary: Number of Participants With Clinical Cure — 20; 33 Participants
Phase 3 N=118 Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
Scabies · Head Lice
Primary: Number of Participants With Headlice — 3 Participants
Phase 3 N=140 Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Scabies
Primary: Proportion of Patients That Are Identified as Cured. — 68; 70 Participants
Phase 3 N=280 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Scabies
Primary: Number of Index Subjects Completely Cured of Scabies After a Single Treatment — 52; 20 Participants
Phase 3 N=291 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
Scabies
Primary: Number of Index Subjects Completely Cured of Scabies After a Single Treatment — 30; 20 Participants
Phase 4 N=1,291 Azithromycin - Ivermectin Mass Drug Administration for Skin Disease
Scabies · Yaws · Impetigo
Primary: Impetigo Prevalence at 12 Months — 79; 66; 20; 12 Cases of impetigo
Phase 2 N=130 A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies
Scabies
Primary: Number of Subjects Who Received a Single Treatment of the Assigned Test Article That Were Designated as "Treatment Success" — 23; 26; 22 Participants — p=0.6084
Phase 3 N=371 A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
Head Lice
Primary: Percentage of Index Participants Who Were Lice-Free by Day 2 That Were Maintained Through Day 15 Post-treatment With Either Ivermectin or Placebo (Vehicle Control) — 71…
Phase 2 N=247 Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
Head Lice
Primary: Percentage of Participants With Treatment Success Following Treatment With Either Ivermectin or Placebo (Vehicle Control) — 95; 53; 83; 49 Percent of Participants
N/A N=29 Efficacy of Cantharidin in Molluscum Contagiosum
Molluscum Contagiosum, Skin Disease
Primary: Patients Experiencing Complete Clearance of All Molluscum Lesions. — 1; 3 Participants
Phase 3 N=410 A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation
Head Lice
Primary: Percentage of Index Participants Who Were Lice-Free by Day 2 That Were Maintained Through Day 15 Post-treatment With Either Ivermectin or Placebo (Vehicle Control) — 76…